• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA API® 32 E 25 STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA API® 32 E 25 STRIPS Back to Search Results
Catalog Number 32400
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of obtaining incorrect identifications when using api® id 32 e (ref 32400, lot 1007394100).The product reference 32400 is not registered in the united states; however, a similar product, api® id 20 e (ref 20100), is registered.The issue was observed with two quality control strains ((b)(4)), and two clinical samples (feces and sputum).The fecal specimen was initially identified as shewanella, then re-identified as pasteurella multocida.The customer got the expected identification of escherichia coli using the id 32 gn product.The sputum specimen initially obtained an unacceptable profile, and results interpreted visually gave the expected identification to serratia marcescens.The two quality control strains used by the customer were not the ones recommended in the ifu.But the customer also obtained incorrect identification for both strains.Escherichia coli (b)(4) was identified as salmonella cholerae arizona, and klebsiella pneumoniae (b)(4) was identified as enterobacter aerogenes.A field application specialist performed retest, but did not confirm the issue observed by the customer.There is no indication or report from the laboratory that the discrepant result led to any adverse event related to any patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in china regarding incorrect identifications when using api® id 32 e (ref 32400, lot 1007394100).The product reference 32400 is not registered in the united states; however, a similar product, api® id 20 e (ref 20100), is registered.The issue was observed with two quality control strains (atcc® 25922¿ and atcc® 700603¿), and two clinical samples (feces and sputum).The fecal specimen was initially identified as shewanella, then re-identified as pasteurella multocida.The customer got the expected identification of escherichia coli using the id 32 gn product.The sputum specimen initially obtained an unacceptable profile, and results interpreted visually gave the expected identification to serratia marcescens.The two quality control strains used by the customer were not the ones recommended in the ifu.But the customer also obtained incorrect identification for both strains.Escherichia coli atcc® 25922¿ was identified as salmonella cholerae arizona, and klebsiella pneumoniae atcc® 700603¿ was identified as enterobacter aerogenes.A field application specialist performed a retest on the patient strains, but did not confirm the issue observed by the customer.A biomérieux internal investigation was performed on the atcc® quality control strains to check the performance of the impacted lot number.Retained samples analysis: biomérieux tested retains from the customer lot 1007394100 and an internal reference lot 1007467090.The conformity was confirmed with the atcc® quality control strains tested for the release of this reference: escherichia coli atcc® 11775¿.Salmonella spp atcc® 35664¿.Raoultella ornithinolitica atcc® 31898¿.Stenotrophomonas maltophilia atcc® 51331¿.The results obtained for these strains with both lots are in agreement with quality control specifications.The customer issue was not reproduced on package insert quality control strain and the retained sample tested.It was recommended for the customer to repeat the instruction for use step by step to validate methodology and perform quality control tests with strains recommended in the package insert.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
API® 32 E 25 STRIPS
Type of Device
API® 32 E 25 STRIPS
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme, les grottes isere 38390
FR  38390
MDR Report Key9527737
MDR Text Key217723779
Report Number9615754-2019-00146
Device Sequence Number1
Product Code JSS
Combination Product (y/n)N
PMA/PMN Number
C1 EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/04/2020
Device Catalogue Number32400
Device Lot Number1007394100
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/27/2019
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer Received02/18/2020
Supplement Dates FDA Received03/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-